FDA Inspection 1078732 — Good Samaritan Hospital Blood Bank
The FDA completed an inspection of Good Samaritan Hospital Blood Bank on Jan 18, 2019 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 18, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Los Angeles, CA (United States)